TMCnet News
Syneos Health Wins Best CRO Award at the Vaccine Industry Excellence AwardsMORRISVILLE, N.C., April 22, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has been named the Best Contract Research Organization (CRO) at the Vaccine Industry Excellence (ViE) Awards. Presented at the World Vaccine Congress in Washington, D.C., the awards recognize the efforts and achievements of companies and individuals in the vaccine industry during the previous year. “We are honored to be selected by biopharmaceutical companies and industry experts for this prestigious award, recognizing the strength of our end-to-end vaccine solutions,” said Paul Colvin, President, Syneos Health Clinical Solutions. “It’s reflective of both our employee and innovation efforts – from the creation of a high-quality Catalyst Vaccine Network to the development of proprietary data monitoring and eCRF (electronic case form) standards – that are delivering superior value for our customers.” Syneos Health’s global vaccine expertise spans the clinical and commercial continuum, fueling the development or commercialization of six vaccines approved by the FDA in a recent five-year period. The Company accelerates vaccine study-start up timelines through the Syneos Health Catalyst Vaccine Network, an integrated team of hand-picked, high-performing sites, Institutional Review Boards (IRB) and key solutions partners. Leveraging the Catalyst Vaccne Network, Syneos Health can deliver vaccine studies for US-based vaccine trials more quickly and predictably, enabling database live and sites activated within 30 days. The ViE Best CRO award winner is selected by industry leaders who vote online for their preferred provider. The finalists are then evaluated by a judging panel on criteria including range of services provided in niche and core therapeutic areas, attention to and quality of relationships with customers and methods of performance improvement. About Syneos Health Investor Relations Contact: Press/Media Contact: |